Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach

Fig. 2

CNPs enhanced anti-tumor activity of anti-PD1 antibody (aPD1). (A) Treatment and analysis schedule. (B) Tumor growth curve. (C) INF-γ secretion in sera. (D) The infiltration of CD3+CD4+ T cells in tumor tissues. (E) The infiltration of CD3+CD8+ T cells in tumor tissues. (F) Tumor growth curves. (G) INF-γ secretion in sera. The data were presented as means ± s.d. Statistical significance was calculated by one-way analysis of variance (ANOVA). (n = 5), *, P < 0.05; **, P < 0.01

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us